Cas No.: | 1446790-62-0 |
Chemical Name: | RO-0921,RO 0921 |
Synonyms: | RO-0921,RO 0921 |
SMILES: | C(NC1=CC(N[C@@H]2[C@H](N)CCCC2)=NN=C1C(=O)N)1=CC=C(C)C(C)=N1 |
Formula: | C18H25N7O |
M.Wt: | 355.44 |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | RO9021 is an orally bioavailable, novel ATP-competitive inhibitor of SYK, with an average IC50 of 5.6 nM. |
In Vitro: | RO9021 is a highly selective SYK inhibitor with low S-scores of 0.003 for S(99) and 0.015 for S(90), indicating that SYK is the only kinase with 99% competition with RO9021 in a total of 392 tested kinases. RO9021 inhibits anti-IgM induced phosphorylation of BTK, PLCγ2, AKT and ERK, indicating that blockade of SYK kinase activity by RO9021 results in attenuation of BCR downstream signaling cascade. RO9021 selectively suppresses B-cell receptor signaling. RO9021 also displays a similar inhibitory potency (IC50=22.8±1.7 nM) in a FcεR-mediated mast cell activation and degranulation assay[1]. |